These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
4. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies]. Michallet M; Dhedin N; Michallet AS Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
7. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Jones SC; Murphy GF; Korngold R Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217 [TBL] [Abstract][Full Text] [Related]
8. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors. Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation: relation between chimaerism and immunity. Vossen J Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764 [TBL] [Abstract][Full Text] [Related]
11. Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Denier C; Bourhis JH; Lacroix C; Koscielny S; Bosq J; Sigal R; Said G; Adams D Neurology; 2006 Dec; 67(11):1990-7. PubMed ID: 17159106 [TBL] [Abstract][Full Text] [Related]
12. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944 [TBL] [Abstract][Full Text] [Related]